What we do
Market Access & Value Strategy
We identify opportunities to demonstrate product value and optimize global market access through therapeutic area landscape assessments, strategic evidence generation plans, payer research, and development of dynamic market access trainings.- Evidence gap and analogue analyses
- Primary payer research and advisory boards
- Evidence generation planning and HTA engagement strategy
Economic Modelling & Evidence Synthesis
Strategic guidance for value demonstration to policymakers through economic models, evidence synthesis and real-world evidence. This includes Health Economics and HTA strategy development, Cost-effectiveness and budget impact models and Microsimulation models.- HTA and reimbursement submissions
- Cost-effectiveness and budget impact models
- SLRs, NMAs, and MAICs
Value Communications
We develop strategic communication plans to demonstrate product value across stakeholders through publications and conference materials, creation of payer value proposition and value messages, and newsletters with the latest industry insights.- Global value dossiers and AMCP dossiers
- Value proposition development and testing
- Scientific abstract, poster, and manuscript development
Partner with Maple
We are a global strategy consulting firm providing strategic Market Access and Health Economics insight across all phases of an asset’s development.
Explore our case studies
AMCP dossier
Maple Health Group develops an AMCP dossier for PRODUCT X to aid US payers in their formulary decision-making process Client feedback Maple Health Group has...
Read moreIndirect treatment comparison
Network meta-analysis to assess the clinical value of PRODUCT X in RRMS. Client feedback The client engaged Maple Health Group on follow-on workstream for developing...
Read moreCost-utility and budget impact model
Cost-utility and budget impact model to communicate the economic value of PRODUCT X in R/R ALL Client Feedback Maple Health Group was engaged for adaptations...
Read more